BMS-929075

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-929075, covering 2013-06-21 to 2013-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients [Phase 1]